Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Other Operating Expenses (2016)

Historic Other Operating Expenses for Tenax Therapeutics (TENX) over the last 5 years, with Q4 2016 value amounting to $33.3 million.

  • Tenax Therapeutics' Other Operating Expenses changed N/A to $33.3 million in Q4 2016 from the same period last year, while for Sep 2017 it was $33.3 million, marking a year-over-year change of. This contributed to the annual value of $33.3 million for FY2016, which is N/A changed from last year.
  • As of Q4 2016, Tenax Therapeutics' Other Operating Expenses stood at $33.3 million.
  • Tenax Therapeutics' 5-year Other Operating Expenses high stood at $33.3 million for Q4 2016, and its period low was $363691.0 during Q2 2012.
  • Moreover, its 4-year median value for Other Operating Expenses was $712916.5 (2013), whereas its average is $8.8 million.
  • In the last 5 years, Tenax Therapeutics' Other Operating Expenses surged by 2040.99% in 2012 and then surged by 750.06% in 2013.
  • Tenax Therapeutics' Other Operating Expenses (Quarter) stood at $363691.0 in 2012, then increased by 7.5% to $390970.0 in 2013, then skyrocketed by 164.69% to $1.0 million in 2015, then skyrocketed by 3114.44% to $33.3 million in 2016.
  • Its Other Operating Expenses stands at $33.3 million for Q4 2016, versus $1.0 million for Q2 2015 and $390970.0 for Q2 2013.